Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) have been given an average recommendation of “Buy” by the six analysts that are currently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $12.13.
BIOX has been the topic of a number of research reports. Lake Street Capital dropped their price target on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, September 11th. Canaccord Genuity Group lowered their target price on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Roth Mkm reduced their price target on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, September 11th. Finally, Oppenheimer lowered their price objective on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a research report on Monday, October 21st.
View Our Latest Analysis on BIOX
Hedge Funds Weigh In On Bioceres Crop Solutions
Bioceres Crop Solutions Stock Up 1.6 %
BIOX stock opened at $6.19 on Friday. The stock has a market cap of $389.03 million, a P/E ratio of 309.65 and a beta of 0.51. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.37. Bioceres Crop Solutions has a twelve month low of $5.71 and a twelve month high of $14.05. The company’s 50 day moving average is $6.75 and its two-hundred day moving average is $8.86.
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last announced its quarterly earnings results on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.11). Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. The company had revenue of $92.60 million for the quarter, compared to analyst estimates of $117.15 million. During the same quarter in the prior year, the business earned ($0.07) earnings per share. Research analysts expect that Bioceres Crop Solutions will post 0.12 earnings per share for the current fiscal year.
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Recommended Stories
- Five stocks we like better than Bioceres Crop Solutions
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- 3 Ways To Invest In Coffee, Other Than Drinking It
- CarMax Gets in Gear: Is Now the Time to Buy?
- Why Invest in 5G? How to Invest in 5G Stocks
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.